Form 4: iRhythm Technologies EVP Adjusts Share Holdings Through ESPP Acquisition and Tax-Related Sale

Sumi Shrishrimal, EVP and Chief Risk Officer of iRhythm Technologies, Inc. (IRTC), reported an acquisition of shares via an Employee Stock Purchase Plan and a subsequent sale to cover tax obligations related to Restricted Stock Unit vesting.

Summary

• Sumi Shrishrimal, EVP and Chief Risk Officer of iRhythm Technologies, Inc. (IRTC), acquired 176 shares of common stock on May 30, 2025, at a price of $71.46 per share.
• This acquisition was made pursuant to the Issuer's 2016 Employee Stock Purchase Plan (ESPP) for the purchase period from December 1, 2024, through May 31, 2025, and is exempt from Section 16(b) under Rule 16b-3.
• Following this acquisition, Ms. Shrishrimal's direct beneficial ownership stood at 36,293 shares.
• On June 2, 2025, Ms. Shrishrimal disposed of 1,608 shares of common stock at a price of $140.21 per share.
• These shares were sold specifically to cover tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units.
• After both transactions, Ms. Shrishrimal's direct beneficial ownership of iRhythm Technologies common stock is 34,685 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing reports routine insider transactions, including an ESPP acquisition and a sale for tax withholding, which are common and do not typically signal a significant change in company outlook or executive confidence beyond standard compensation management.

Positives

• The acquisition of 176 shares through the Employee Stock Purchase Plan indicates continued participation by an executive in the company's equity program, aligning executive interests with shareholder value.

Negatives

• The sale of 1,608 shares, while for tax withholding purposes, results in a reduction of the executive's direct beneficial ownership.

Future Outlook

N/A

Industry Context

This Form 4 filing details routine insider transactions for an executive at iRhythm Technologies, a company operating in the medical device and digital health sector, specifically focusing on cardiac monitoring. Such transactions are common for executives managing their equity compensation and tax obligations.

Stakeholder Impact

• Shareholders: Provides transparency into executive share ownership and routine compensation-related transactions. The sale for tax purposes is a common occurrence and generally not indicative of a lack of confidence in the company's future.

Key Dates

Keywords

iRhythm Technologies, IRTC, Form 4, Insider Trading, Stock Ownership, Employee Stock Purchase Plan, Restricted Stock Units, Tax Withholding, Executive Compensation